Novel therapeutics and emerging technology in haemostasis and thrombosis: highlights from the British society for haemostasis and thrombosis annual meeting

Claire S Whyte; Gael B Morrow; Julia S Gauer; Samantha J Montague; Philip L R Nicolson

doi:10.3389/fcvm.2023.1225243

Novel therapeutics and emerging technology in haemostasis and thrombosis: highlights from the British society for haemostasis and thrombosis annual meeting

Front Cardiovasc Med. 2023 Sep 7:10:1225243. doi: 10.3389/fcvm.2023.1225243. eCollection 2023.

Authors

Claire S Whyte¹, Gael B Morrow^{1

2}, Julia S Gauer³, Samantha J Montague⁴, Philip L R Nicolson^{4

5}

Affiliations

¹ Aberdeen Cardiovascular and Diabetes Centre, School of Medicine, Medical Sciences and Nutrition, Institute of Medical Sciences, University of Aberdeen, Aberdeen, United Kingdom.
² Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.
³ Discovery and Translational Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, United Kingdom.
⁴ Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
⁵ West Midlands Haemophilia Comprehensive Care Centre, University Hospitals Birmingham Foundation Trust, Birmingham, United Kingdom.

Abstract

The 2023 annual meeting of the British Society for Haemostasis and Thrombosis (BSHT) was held in Birmingham, United Kingdom. The theme of this year's meeting was novel therapeutics and emerging technology. Here, the exciting research presented at the meeting is discussed.

Keywords: bleeding; coagulation; fibrinolysis; haemostasis; platelets; thrombosis.